Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anteris Technologies Global (AVR) Depreciation & Amortization (CF) (2024 - 2026)

Anteris Technologies Global (AVR) reported Depreciation & Amortization (CF) of $429000.0 for Q1 2026, up 6.45% year-over-year from $403000.0 in Q1 2025, and up 1.42% on a QoQ basis from $423000.0 in Q4 2025.

Anteris Technologies Global (AVR) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $429000.0 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 6.45% year-over-year to $429000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 7.8% YoY) and the FY2025 annual result came in at $1.7 million, up 10.22% from the prior year.
  • Depreciation & Amortization (CF) advanced to $429000.0 in Q1 2026 per AVR's latest filing, from $423000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $429000.0 in Q1 2026 and bottomed at $345000.0 in Q1 2024.
  • The 3-year median for Depreciation & Amortization (CF) is $404000.0 (2024), against an average of $399666.7.
  • Peak annual rise in Depreciation & Amortization (CF) reached 16.81% in 2025, while the deepest fall reached 4.7% in 2025.
  • Tracing AVR's Depreciation & Amortization (CF) over 3 years: stood at $404000.0 in 2024, then rose by 4.7% to $423000.0 in 2025, then advanced by 1.42% to $429000.0 in 2026.
  • Per Business Quant, the three latest AVR Depreciation & Amortization (CF) figures stand at $429000.0 (Q1 2026), $423000.0 (Q4 2025), and $417000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 178.90 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 563.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 58.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 44.60 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 135.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 95.50 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 56.55 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 237.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 64.31 Mn
10 Anteris Technologies Global 753.31 Mn 753.28 Mn 380,000.00 429,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 429,000.00
Mar 31, 2026 429,000.00
Dec 31, 2025 423,000.00
Dec 31, 2025 423,000.00
Sep 30, 2025 417,000.00
Sep 30, 2025 417,000.00
Jun 30, 2025 418,000.00
Jun 30, 2025 418,000.00
Mar 31, 2025 403,000.00
Mar 31, 2025 403,000.00
Dec 31, 2024 404,000.00
Dec 31, 2024 404,000.00
Sep 30, 2024 381,000.00
Sep 30, 2024 381,000.00
Jun 30, 2024 377,000.00
Jun 30, 2024 377,000.00
Mar 31, 2024 345,000.00
Mar 31, 2024 345,000.00